Drug Type siRNA |
Synonyms |
Target |
Mechanism 17β-HSD13 inhibitors(17-beta-hydroxysteroid dehydrogenase 13 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 2 | CN | 08 Mar 2024 |